AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 238: G434-G439, 1980;
0193-1857/80 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bond, J. H.
Right arrow Articles by Levitt, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bond, J. H.
Right arrow Articles by Levitt, M. D.

AJP - Gastrointestinal and Liver Physiology, Vol 238, Issue 5 434-G439, Copyright © 1980 by American Physiological Society


ARTICLES

Effect of glucagon on gastrointestinal blood flow of dogs in hypovolemic shock

J. H. Bond and M. D. Levitt

A microsphere technique was used to study the effect of glucagon on blood flow to the different tissue layers of the stomach, small bowel, and colon of the dog in hypovolemic shock. In normal dogs, glucagon caused a twofold rise in flow to all layers of the stomach and colon, and a threefold increase to all layers of the small bowel. After administration of glucagon, a larger fraction of cardiac output was diverted to the gut microcirculation. In acute hypovolemic shock, intestinal perfusion was preserved relative to cardiac output inasmuch as cardiac output and gastric blood flow fell 75% and flow to the small bowel and colon fell by only about 50%. Glucagon markedly increased the fraction of cardiac output passing to the gut circulation in hypovolemic shock and, most importantly, sustained flow to the areas most prone to ischemic necrosis; gastric mucosa, colonic mucosa, and small intestinal villi. In more prolonged shock, however, glucagon precipitated fatal cardiovascular collapse unless part of the lost blood volume first was replaced. Glucagon, therefore, should not be used in patients in hypovolemic shock without prior replacement of at least part of the lost blood volume.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online